Search by Drug Name or NDC

NDC 59651-0166-30 Emtricitabine and Tenofovir Disoproxil Fumarate 133; 200 mg/1; mg/1 Details

Emtricitabine and Tenofovir Disoproxil Fumarate 133; 200 mg/1; mg/1

Emtricitabine and Tenofovir Disoproxil Fumarate is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Aurobindo Pharma Limited. The primary component is EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE.

MedlinePlus Drug Summary

The combination of emtricitabine and tenofovir (Descovy, Truvada) is used along with other medications to treat HIV in adults and children who weigh at least 37 pounds (17 kg). Emtricitabine and tenofovir (Truvada) is also used along with practicing safer sex (e.g., condom use) to reduce the risk of HIV infection) in high-risk adults and teenagers who weigh at least 77 pounds (35 kg). Emtricitabine and tenofovir are in a class of medications called nucleoside and nucleotide reverse transcriptase inhibitors (NRTIs). They work by slowing the spread of HIV in the body. Although emtricitabine and tenofovir will not cure HIV, these medications may decrease your chance of developing acquired immunodeficiency syndrome (AIDS) and HIV-related illnesses such as serious infections or cancer. Taking these medications along with practicing safer sex and making other lifestyle changes may decrease the risk of getting or transmitting the HIV virus to other people.

Related Packages: 59651-0166-30
Last Updated: 04/28/2024
MedLinePlus Full Drug Details: Emtricitabine and Tenofovir

Product Information

NDC	59651-0166
Product ID	59651-166_a805c27a-1154-4aac-9af8-bbd755be027f
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Emtricitabine and Tenofovir Disoproxil Fumarate
Proprietary Name Suffix	n/a
Non-Proprietary Name	Emtricitabine and Tenofovir Disoproxil Fumarate
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET, FILM COATED
Route	ORAL
Active Ingredient Strength	133; 200
Active Ingredient Units	mg/1; mg/1
Substance Name	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
Labeler Name	Aurobindo Pharma Limited
Pharmaceutical Class	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleosi
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA211640
Listing Certified Through	2025-12-31

Package

NDC 59651-0166-30 (59651016630)

Pricing Information	N/A
NDC Package Code	59651-166-30
Billing NDC	59651016630
Package	30 TABLET, FILM COATED in 1 BOTTLE (59651-166-30)
Marketing Start Date	2023-03-09
NDC Exclude Flag	N